Supplemental material
Leukemia & Lymphoma
Volume 63, 2022 - Issue 13
Articles
A natural history of lower-risk myelodysplastic syndromes with ring sideroblasts: an analysis of the MDS-CAN registry
Rena Bucksteina Division of Medical Oncology & Hematology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada;b Department of Medicine, University of Toronto, Toronto, ON, CanadaCorrespondence[email protected]
https://orcid.org/0000-0001-9520-7386View further author information
https://orcid.org/0000-0001-9520-7386View further author information, , , Karen W.L Yeeb Department of Medicine, University of Toronto, Toronto, ON, Canada;c Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canadahttps://orcid.org/0000-0002-2572-9952View further author information
https://orcid.org/0000-0002-2572-9952View further author information, Michelle Geddesd Tom Baker Cancer Centre, Calgary, AB, Canadahttps://orcid.org/0000-0003-1662-6000View further author information
https://orcid.org/0000-0003-1662-6000View further author information, , , Heather A. Leitchg St. Paul’s Hospital, University of British Columbia, Vancouver, BC, Canadahttps://orcid.org/0000-0002-7899-2025View further author information
https://orcid.org/0000-0002-7899-2025View further author information, Grace Christouh Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canadahttps://orcid.org/0000-0003-0453-8046View further author information
https://orcid.org/0000-0003-0453-8046View further author information, Versha Banerjii CancerCare Manitoba, Winnipeg, MB, Canadahttps://orcid.org/0000-0002-7415-8818View further author information
https://orcid.org/0000-0002-7415-8818View further author information, , , , , , , , , Anne Parmentiera Division of Medical Oncology & Hematology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canadahttps://orcid.org/0000-0001-5695-9622View further author information
https://orcid.org/0000-0001-5695-9622View further author information, , , , Chris Cameronq Value and Evidence Division, Marketing & Market Access, EVERSANA™, Sydney, NS, Canadahttps://orcid.org/0000-0003-3613-760XView further author information
https://orcid.org/0000-0003-3613-760XView further author information, Alexandre Mamedova Division of Medical Oncology & Hematology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canadahttps://orcid.org/0000-0002-7395-3617View further author information
https://orcid.org/0000-0002-7395-3617View further author information, Paul Spinq Value and Evidence Division, Marketing & Market Access, EVERSANA™, Sydney, NS, Canadahttps://orcid.org/0000-0002-4622-3547View further author information
https://orcid.org/0000-0002-4622-3547View further author information & show all